Latest filing published 05 Feb 2025 for 대한약품.
이승영: trading record in brief
이승영 is a declared insider of 대한약품, with filings sourced from DART (FSS). Over a trading history stretching from 25 January 2022 to 5 February 2025, the count stands at 9 filings.
Purchases make up the whole of the open-market record (7 purchases, €7,634). The amount is not disclosed for 5 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2025 alone, the filings show 1 purchase and no sales.
The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The latest filing, published on 5 February 2025, reports an open-market purchase in 대한약품. Filings reach the DART (FSS) feed a median of 6 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 이승영
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ShareKRXDART:20241121000333Canonical exit: 19 Feb 2025 (T+90)
- ShareKRXDART:20240912000313Canonical exit: 11 Dec 2024 (T+90)
- ShareKRXDART:20240830001762Canonical exit: 28 Nov 2024 (T+90)
- ShareKRXDART:20240813001189Canonical exit: 11 Nov 2024 (T+90)
9 of 9 declarations